MGNX

MacroGenics, Inc.

2.40

USD

-0.07

-2.63%

Oct 29, 15:23 UTC -4

Open

MacroGenics, Inc. (MGNX) Earnings

MGNX Earnings Reports

Positive Surprise Ratio

MGNX beat 19 of 43 last estimates.

44%

Next Report

Next Week

Date of Next Report

Nov 04, 2026

Estimate for Q3 26 (Revenue/ EPS)

$47.33M

-$0.06

Implied change from Q2 26 (Revenue/ EPS)

+44.16%

-76.92%

Implied change from Q3 25 (Revenue/ EPS)

-35.02%

-122.22%

MacroGenics, Inc. earnings per share and revenue

On Aug 13, 2026, MGNX reported earnings of -0.26 USD per share (EPS) for Q2 26, missing the estimate of -0.12 USD, resulting in a -102.65% surprise. Revenue reached 32.83 million, compared to an expected 68.80 million, with a -52.28% difference. The market reacted with a +3.43% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 6 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 47.33 million USD, implying an decrease of -76.92% EPS, and increase of 44.16% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Sundial Growers Inc. Common Shares

Report Date

Oct 27, 2026 For Q3 26

Estimate

-$0.02

Actual

-$0.04

Surprise

-101.26%

Abbott Laboratories

Report Date

Oct 21, 2026 For Q3 26

Estimate

$1.42

Actual

$1.42

Surprise

-0.68%

Boston Scientific Corp.

Report Date

Oct 28, 2026 For Q3 26

Estimate

$0.72

Actual

$0.73

Surprise

+1.05%

GE HealthCare Technologies Inc. Common Stock

Report Date

Oct 28, 2026 For Q3 26

Estimate

$1.22

Actual

$1.34

Surprise

+9.13%

Baxter International Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

$0.52

Actual

$0.57

Surprise

+10.86%

FAQ

What were MacroGenics, Inc.'s earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, MacroGenics, Inc. reported EPS of -$0.26, missing estimates by -102.65%, and revenue of $32.83M, -52.28% below expectations.

How did the market react to MacroGenics, Inc.'s Q2 2026 earnings?

The stock price moved up 3.43%, changed from $4.08 before the earnings release to $4.22 the day after.

When is MacroGenics, Inc. expected to report next?

The next earning report is scheduled for Nov 04, 2026.

What are the forecasts for MacroGenics, Inc.'s next earnings report?

Based on 6 analysts, MacroGenics, Inc. is expected to report EPS of -$0.06 and revenue of $47.33M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.